Clinical data | |
---|---|
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider |
|
UNII | |
KEGG |
|
ChEBI | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.053.428 |
Chemical and physical data | |
Formula | C17H13ClN2O2 |
Molar mass | 312.75 g·mol−1 |
3D model (JSmol) | |
| |
| |
NY (what is this?) (verify) |
Lonazolac is a nonsteroidal anti-inflammatory drug (NSAID).
pyrazolones / pyrazolidines | |
---|---|
salicylates | |
acetic acid derivatives and related substances | |
oxicams | |
propionic acid derivatives (profens) |
|
n-arylanthranilic acids (fenamates) | |
COX-2 inhibitors (coxibs) | |
other | |
NSAID combinations | |
Key: underline indicates initially developed first-in-class compound of specific group; # WHO-Essential Medicines; † withdrawn drugs; ‡ veterinary use. | |
This drug article relating to the musculoskeletal system is a stub. You can help Wikipedia by expanding it. |